Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Psoriasis

Man credits diet change and £19.99 skin cream for treating his psoriasis - OLD

Scot Cunningham, 27, from Salford, Greater Manchester is looking forward to celebrating Pride this weekend.

The Independent UK

Cara Delevingne's life - Amber Heard rumours to secret health battle as she turns 30

Model and actress Cara Delevingne has enjoyed a varied career and is set to embark on a new challenge presenting a six-part documentary series called Planet Sex

Daily Mirror

Woman feared people were 'staring at her' after developing skin condition

Paige said it is easier for her to accept it is there for life

Liverpool Echo

From analysis to the latest developments in health,
read the most diverse news in one place.

Woman says 70% of her body is covered in red marks due to rare condition

Bri Morrell from Leicester was diagnosed with psoriasis, an irritating skin condition which causes red, scaly patches to appear on her skin

Daily Mirror

Family's warning as baby breaks out in rash before developing 'worst case' of condition

Medics said Mabel Gilmore was suffering the worst case of a chronic skin condition they had seen

Manchester Evening News

Mum's warning as baby breaks out in red rash that looks like burns

Mabel Gilmore broke out in a painful red rash that looked like burns just days before her first birthday

Liverpool Echo

Psoriasis symptoms and signs your scaly skin patches could be immune disease

Psoriasis is an immune disease that causes red and crusty patches of skin covered with silvery scales. Here's everything you need to know about types and symptoms of the disease

Daily Mirror

Read news from The Economist, FT, and more,
with one subscription

Does my child have psoriasis or is it just a rash?

Health experts explain the symptoms and causes of the skin condition. By Katie Wright.

The Independent UK

Recap Of Friday's Biotech Catalysts - End of The Day Summary

The U.S. Food and Drug Administration (FDA) has approved Arcutis Biotherapeutics’ (NASDAQ:ARQT) New Drug Application (NDA) for ZORYVE (roflumilast) cream 0.3% for the treatment of plaque psoriasis in patients 12 years of age or older. The company expects commercial launch of the product in Mid-August. Arcutis shares traded in a range of…

Benzinga

'I struggle to sleep and can't wear tight clothes, it's like I have sunburn all the time'

A woman has shared how she struggles to get to sleep at night and is unable to wear bras or tight clothing as 80 per cent of her body is covered in 'burning psoriasis'

Daily Mirror

Kim Kardashian's psoriasis battle as fans spot red leg mark in unfiltered bikini pics

Kim Kardashian has been spotted struggling with a flare-up of psoriasis. She's been open about her battle with the painful autoimmune disease throughout her career

Daily Mirror

Nurse had sore throat and ended up with 'leopard print' skin

A nurse has claimed that a sore throat left her with 'leopard print' skin condition

Wales Online

Best products to help treat psoriasis: Top creams, balms and lotions

Help soothe and heal with these carefully formulated body and skincare buys

Evening Standard

How to keep your summer skin problems under control as many avoid leaving house

Eczema, vitiligo, prickly heat, sunscreen sensitivity, acne and psoriasis can become a real misery as the days get longer, hotter and stickier in the summer

Daily Mirror

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates

The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment.

Daily Mirror

Nurse, 22, had sore throat which led to her developing scaly 'leopard print skin'

Ashling Armstrong, a 22-year-old nurse from Belfast, developed a sore throat which doctors said triggered Guttate psoriasis, a skin condition which left her with "scaly" skin

Manchester Evening News

Nurse, 22, says sore throat left her with 'leopard print skin'

Ashling Armstrong says she gets people staring 'everyday' at her skin

Benzinga

Can-Fite BioPharma Shares Jump After Piclidenoson Data In Psoriasis Trial

Can-Fite BioPharma Ltd (NYSE:CANF) announced topline results from the COMFORT Phase 3 trial of Piclidenoson in more than 400 adults with moderate to severe plaque psoriasis. The study data show that patients treated with oral Piclidenoson 2 mg or 3 mg twice daily had clinically equivalent efficacy responses. At week 16, patients receiving…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Soligenix Gets FDA Nod For Mid-Stage Psoriasis Study

The U.S. Food and Drug Administration (FDA) has cleared Soligenix’s (NASDAQ: SNGX) Investigational New Drug (IND) application for Phase 2a clinical trial Evaluating SGX302 in the treatment of patients with Mild-to-Moderate Psoriasis.

Chronicle Live

Mum given devastating choice between life-changing medication and having a baby

Rebecca Sayers suffers from the lifelong chronic skin condition psoriasis

Daily Mirror

Student blames horrific 'red raw' sores covering 90% of body on sharing vapes with pals

Emily Angel Pellegrini, 21, visited the doctor after she first noticed a tiny scab under her boob at the start of the year but just dismissed it as friction from her bra

The Guardian - UK

Letter: Lady Knight of Collingtree obituary

Ray Jobling writes: Jill Knight made a great contribution to the Psoriasis Association

Benzinga

Can-Fite Q1 Revenue Increases 38.5%, Phase III Psoriasis Treatment Study Results Expected In Q2

Can-Fite BioPharma Ltd. (AMEX:CANF) (TASE: CFBI) released financial results for the quarter ended March 31, 2022, revealing revenue of $200,000, an increase of or 38.5%, compared to $150,000 in Q1 2021. Q1 Financial Highlights

Benzinga

This Mid-Cap Firm Can Potentially Offer Biggest Oral Drug In Atopic Dermatitis, Cantor Thinks So

Cantor assumes coverage of RAPT Therapeutics Inc (NASDAQ:RAPT) with an Overweight rating and a price target of $44 (vs. $58 previously). The analyst says the company's RPT193 (lead inflammation drug) could be a $3 billion drug in just atopic dermatitis (AD) indication, as it expects AD to outperform psoriasis. Cantor suggests that ‘193 is…

Benzinga

SNGX: Phase 2a Trial of SGX302 in Psoriasis to Initiate in Second Half of 2022…

By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Kennedy News and Media

US Food and Drug Administration

62 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.